Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers found that Truvada as pre-exposure prophylaxis greatly reduced HIV cases in both people on PrEP and those not on it.
The decline has nothing to do with fewer hookups during COVID-19 lockdowns.
Plus: Their stigma-busting initiative gets a shout-out from POZ’s Best Celebrity Advocate 2019.
The country’s National Health Service was to provide the HIV prevention drug for free starting this spring.
The famed London sexual health clinic 56 Dean Street revealed that post-exposure prophylaxis prescriptions declined dramatically.
Researchers attribute this dramatic shift to routine testing and access to direct-acting antiviral treatment for hep C.
The country’s National Health Service will pay for the drug as part of its goal to end HIV transmission by 2030.
In a recent small study, resistance was limited to the emtricitabine component of Truvada and did not seem a major cause for concern.
A pair of studies analyzed brief smoking-cessation interventions initiated by health care providers.
It’s not just because of PrEP, which isn’t even easily available in England.
Watch rugby star Gareth Thomas discuss HIV with Prince Harry.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.
HIV-positive men who have sex with men in Western nations historically have a significant risk of contracting hepatitis C through sex.
The diagnosis rate fell by 50 percent in just two years among gay and bi men who attended sexual clinics at least twice in one year.
The largest-ever HIV prevention study found that door-to-door HIV testing, with linkage to treatment, lowered infection rates.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.